Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update for tralokinumab in adults and adolescents with oral corticosteroid-dependent asthma; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2018-05-16